Correction of Anticoagulant Therapy in Patients with Severe COVID-19 Virus Infection Using a Thrombodynamics Coagulation Assay

BACKGROUND: The average frequency of thrombosis in patients with COVID-19 is still high despite low molecular weight heparin (LMWH) prophylactic. Global hemostasis assays, particularly thrombodynamics (TD), known to be sensitive to both hypercoagulation and heparin effects, could potentially be usef...

Descripción completa

Detalles Bibliográficos
Autores principales: Vuimo, Tatiana S., Tsarenko, Sergey V., Filimonova, Elena V., Seregina, Elena A., Karamzin, Sergey S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Manuscript
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793037/
https://www.ncbi.nlm.nih.gov/pubmed/36560917
http://dx.doi.org/10.1177/10760296221142862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793037/
https://www.ncbi.nlm.nih.gov/pubmed/36560917
http://dx.doi.org/10.1177/10760296221142862

Ejemplares similares